TGFB1 and diabetic kidney disease: In a rat model, sirolimus lowered expression and activity of glomerular transforming growth factor-beta 1/2 and vascular endothelial growth factor, all of which are considered central cytokines in the pathogenesis of diabetic nephropathy [59].